The largest database of trusted experimental protocols

10 protocols using heparin hp column

1

Histone and FACT Complex Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Histones H2A, H2B, H3 and H4 were cloned into pET3a histone expression plasmid, overexpressed in E. coli, and purified from inclusion bodies50 (link). The purified histone ubH2B was purchased from KS-V Peptide Biological Technology Co., Ltd (Hefei, China), by total chemical synthesis utilizing standard solid phase peptide synthesis and peptide fragments ligation reactions to generate the desired protein51 (link). For the purification of recombinant FACT complex19 (link),27 (link), Sf9 cells (1.5–2 × 106/ml) were infected with baculovirus containing Flag-SPT16 and His6-SSRP1, and incubated at 27 °C for 72 h. The infected cells were collected and washed with ice-cold PBS, and then lysed in lysis buffer (150 mM NaCl, 20 mM Tris-HCl, pH 8.0, 5% glycerol, 1 mM PMSF). 10 mg (60 mL) of the cell extracts were incubated with 500 μL anti-Flag M2-agarose (Sigma, A2220) for 4 h at 4 °C, with the resin washed by lysis buffer. Bound proteins were eluted in the presence of 0.5 mg/ml Flag peptide (Sigma, F4799) and further purified by a Heparin HP column (GE Healthcare). The fractions containing FACT complex were dialyzed against BC-100 buffer (100 mM NaCl, 10 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, 20% glycerol, 1 mM DTT, 1 mM PMSF) and stored at −80 °C.
+ Open protocol
+ Expand
2

Purification of Recombinant PARP1 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
PARP1 was purified as described previously (32 (link)), with some modifications. Briefly, bacterial pellets [E. coli strain Rosetta 2 (DE3)] from 2 l cultures were resuspended in lysis buffer (25 mM HEPES pH 8.0, 500 mM NaCl, 0.5 mM DTT, 10 mM benzamide) supplemented with 0.1% NP-40, Complete EDTA-free protease inhibitor cocktail (Roche) and 1 mg/ml lysozyme (Sigma) and sonicated four times for 20 s. Then, 5 μg/ml DNase I (Roche) was added and incubated for 1 h. Cell debris were removed by centrifugation (68 000 × g, 2 h), the supernatant was filtered (syringe filter, 0.2 μm, Corning) and loaded onto a HisTrap HP column (GE Healthcare). After washing with 10 ml of 1 M NaCl, PARP1 was eluted with 30 ml of 500 mM imidazole. The elution fraction was diluted to a final NaCl concentration of 375 mM NaCl with no-salt heparin buffer (50 mM Na-phosphate pH 7.0; 1 mM EDTA) and loaded onto a heparin HP column (GE Healthcare). PARP1 was eluted by gradually increasing the NaCl concentration up to 1 M (30 ml). PARP1 containing fractions were concentrated and buffer was exchanged (50 mM Tris pH 8, 150 mM NaCl, 0.5 mM DTT) via centrifugal filters (Amicon Ultra 15, 10 kDa MWCO).
+ Open protocol
+ Expand
3

Hepatitis D Virus Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid pcDNA3.1-HDV-gt3-peru and pT7HB2.7 were used to transfect HuH7 cells using Mirus TransIT LT1 transfection reagent (Mirus, Germany) according to the manufactory’s manual. The supernatant between day 6–12 post transfection was purified and concentrated using Heparin HP column (GE Healthcare) as described37 (link).
+ Open protocol
+ Expand
4

Purification of Methyltransferase Enzymes from E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols

E. coli strain M15 [pREP4] containing the plasmid pQMSsoII or pQMNlaX was grown at 37°C in LB medium with 30 µg/ml kanamycin and 50 µg/ml ampicillin to an A600 value of 0.6. Protein expression was induced with 0.7 mM isopropyl 1-thio-β-D-galactopyranoside, and the cell culture was kept for 20 h at 20°C. The cells were harvested by centrifugation. The cell pellets were resuspended in buffer A (50 mM Na-phosphate, 100 mM NaCl, 5 mM β-mercaptoethanol, 5% (w/v) glycerol, pH 7.0) and lysed by sonication. The lysate was clarified by centrifugation at 18,000 g and loaded onto a Heparin HP column (GE Healthcare) pre-equilibrated with buffer A. The target protein was eluted with a gradient from 0.1 to 1.0 M NaCl. In case of M.SsoII, the fractions containing this protein were loaded onto a HisTrap HP column (GE Healthcare) and eluted with a 20–400 mM imidazole gradient. The target proteins were concentrated and their purity was estimated using 12.5% SDS-PAGE. Because of cytotoxicity of M.SsoII, the yield of purified M.SsoII was 0.14 mg from 1 l of cell culture, two orders of magnitude lower than that of M.NlaX.
+ Open protocol
+ Expand
5

Purification of HerA and NurA Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
HerA and NurA cells were re-suspended in lysis buffer (100 mM NaCl, 50 mM Hepes–NaOH pH 8.0, 5 mM DTT and 5% v/v glycerol) supplemented with an EDTA-Free SigmaFast Protease Inhibitor Cocktail Tablet (Sigma-Aldrich). The cells were lysed by sonication and the lysate was clarified by centrifugation. The supernatant was heated in a 70°C water bath for 20 min and subsequently clarified by centrifugation to remove precipitated protein. The supernatant was then loaded onto a 5 ml Heparin HP column (GE Healthcare) equilibrated with lysis buffer. Bound protein was eluted with a linear gradient from 100 mM to 1 M NaCl. Fractions containing the protein of interest were pooled and dialysed against 100 mM NaCl, 50 mM Hepes–NaOH pH 8.0, 5 mM DTT and 5% (v/v) glycerol for 18 h. The dialyzed protein was loaded onto a 5 mL HiTrap Q HP column (GE Healthcare) equilibrated with lysis buffer. Bound protein was eluted with a linear gradient from 100 mM to 1 M NaCl. Fractions containing the protein of interest were pooled and dialysed against 300 mM NaCl, 20 mM Hepes–NaOH pH 8.0, 5 mM DTT and 5% (v/v) glycerol for 18 h. The protein was concentrated with Amicon Ultra-15 centrifugal filter units (EMD Millipore) and aliquots were flash-frozen in liquid nitrogen and stored at –80°C. Protein concentrations were estimated from absorbance at 280 nm using extinction coefficients.
+ Open protocol
+ Expand
6

Purification and Characterization of Recombinant Human PCSK9

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sequence of human PCSK9 used here is identical to sequence of GenBank acc. no. CAC38896.1. The coding region was ligated into the pCpGfree-vitroNmcs expression vector and transformed into the E. coli strain GT115 encoding the pir gene (Invivogen). CHO-K1 cells stably transfected with PCSK9 were grown as a suspension in Hybridoma-SFM medium (GIBCO) and then expanded to Celline CL 350 Bioreactor flasks (Integra) or in triple layer flasks (Thermo Fischer Scientific). The medium from PCSK9-expressing CHO cells was 1:1 in 25 mM Tris pH 7.4 and applied to two serial-connected 5 mL HiTrap QFF columns (GEhealthcare). The columns were washed with 25 mM Tris pH 7.4 and protein subsequently eluted with 25 mM Tris pH 7.4 and 1 M NaCl. The eluted sample was dialyzed against 25 mM Tris pH 7.4 and 5% (v/v) glycerol at 4°C. The dialyzed sample was applied to a 5 mL Heparin HP column (GEhealthcare) and protein was eluted in 1 mL fractions by a linear gradient over 40 mL from 0 to 1 M NaCl in 25 mM Tris pH 7.4. Fractions containing PCSK9 were concentrated and further purified by SEC on a Superdex200 increase 10/300 or 16/600 in either PBS or 25 mM Tris pH 7.4 and 150 mM NaCl. Samples were analyzed by SDS-PAGE and PCSK9 was concentrated to 5–8 mg/mL based on absorbance at 280 nm and flash-frozen in liquid nitrogen before storage at-80°C.
+ Open protocol
+ Expand
7

Purification and Characterization of SaPriA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The gene SAAV1184, encoding SaPriA, was amplified by PCR using genomic DNA of Staphylococcus aureus subsp. aureus ED98 as template. The forward (5′-GGGAAGGATCCATGATAGCGAAAGTCA-3′) and the reverse (5′-CCATTCTCGAGCATCATCATCTGTGGA-3′) primers were designed, and BamHI and XhoI restriction sites into SaPriA were introduced. The PCR product was then ligated to the pET21b vector. SaPriA was purified by Ni2+-affinity chromatography (GE Healthcare Bio-Sciences) eluted with Buffer A (20 mM Tris–HCl, 250 mM imidazole, and 0.5 M NaCl, pH 7.9). After dialysis against Buffer B (20 mM HEPES and 100 mM NaCl, pH 7.0), the SaPriA solution was further purified by the Heparin HP column (GE Healthcare Bio-Sciences), eluted with a linear NaCl gradient from 0.1 to 1.0 M with Buffer B using the AKTA-FPLC system (GE Healthcare Bio-Sciences). SDS-PAGE was used to show the protein purity (Fig. 1). By the vanadate-sensitive colorimetric assay, the ATPase activity of SaPriA was detected: more the concentration of inorganic phosphate released by ATP hydrolysis, more the OD610 intensity. The binding of kaempferol to SaPriA was analyzed by the fluorescence emission spectra of SaPriA quenched by kaempferol.

SDS-PAGE of the purified SaPriA and molecular mass standards

+ Open protocol
+ Expand
8

Purification of DNMT3A-DNMT3L and DNMT3B-DNMT3L complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MTase domains of human DNMT3A or DNMT3B (DNMT3A MTase: residues 562–853; DNMT3B MTase: residues 628–912) or was co-expressed with residues 178–386 of human DNMT3L on a modified pRSFDuet-1 vector (Novagen), which contains a hexahistidine (His6) and SUMO tag preceding the DNMT3B or DNMT3A sequence. The expression and purification of the DNMT3A-DNMT3L or DNMT3B-DNMT3L complex was as previously described22 (link). In essence, the protein complexes were expressed using the Escherichia coli BL21 DE3 (RIL) cell strains and purified using a Ni2+-NTA column, followed by removal of the His6-SUMO tag through Ubiquitin-like-specific protease 1 (ULP1) cleavage, ion exchange chromatography on a Heparin HP column (GE Healthcare) and size-exclusion chromatography on a HiLoad 16/600 Superdex 200 pg column (GE Healthcare). The final protein samples were concentrated in a buffer containing 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 0.1% β-mercaptoethanol and 5% glycerol, and stored in −80°C before use.
+ Open protocol
+ Expand
9

Fluorescent Protein Labeling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the labeling of the PX, 1 mg of AF647 C2 Maleimide kit (Life Technologies, A20347) was dissolved in 100 μL DMSO (ThermoFischer, Catalog No. BP231-100) to final 7.7 mM. For the final labeling reaction 250 μM PX, 2.5 mM TCEP, 385 μM AF647 dye was mixed with labeling buffer (50 mM HEPES pH 7.0, 200 mM KCl) to a total volume of 1 mL, and the reaction was left for 2 hr at room temperature on a roller at 10 rpm. After the incubation, 1 mM of DTT was added and the protein was loaded on a 5 mL Heparin HP column (GE Healthcare 17040701). The column was first washed with HA buffer (50 mM HEPES PH 8.0, 100 mM KCl, 1 mM TCEP) and then eluted with HB buffer (50 mM HEPES PH 8.0, 1 M KCl, 1 mM TCEP). The peak fractions were pooled and concentrated to 6.7 mg/mL (384 μM) with ~ 20% labelling efficiency.
+ Open protocol
+ Expand
10

Expression, Purification, and Labeling of CENP-T

Check if the same lab product or an alternative is used in the 5 most similar protocols
CENP‐T2‐373 was expressed, purified, and fluorescently labelled as described.27 In brief, the expression of GST‐3C‐CENP‐T2‐373 with a C‐terminal ‐LPETGG extension was induced in Escherichia coli BL21(DE3)‐codon‐plus‐RIL cells through the addition of 0.35 mM IPTG for ~14 hr at 20°C. Subsequent steps were performed at 4°C or on ice. Cleared lysates were prepared by sonication and centrifugation and bound to a Glutathione‐Agarose resin (Serva). GST‐3C‐CENP‐T was cleaved off the beads with in‐house generated 3C protease for 16 hr. After further purification using a Heparin HP column (GE Healthcare), CENP‐T was fluorescently labeled with a GGGGK‐TMR (5‐Carboxytetramethylrhodamine) peptide (GenScript) using the Calcium‐independent Sortase 7 M.40 After size‐exclusion chromatography using a Superdex 200 16/600 column (GE Healthcare) in a buffer containing 20 mM Tris–HCl, pH 8.0, 150 mM NaCl, and 1 mM TCEP, CENP‐T2‐373 TMR was concentrated to 118 μM and stored at −80°C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!